Brasília – Several Brazilian pharmaceutical entities have signed the Manifesto for Regulatory Agencies. This text seeks to expose obstacles faced by government agencies in Brazil. It also indicates possible actions for improvement. Additionally, it guides the debates that have begun in the National Congress.

The House of Representatives has recently begun to debate the functioning of public agencies such as Anvisa. The Agency has been constantly criticized for a crisis of inefficiency and slowness. The health agency was even called out by President Lula, at an event organized by EMS in August.

The text is supported by entities such as ABIIS, ABIMED, ABIMO, ABIFINA, ABIFISA, ABIQUIFI, ABRALDI, ABRASP, ACESSA, ALANAC, CBDL, Grupo Farma Brasil, Interfarma, PróGenéricos, Sinfar-RJ, Sindicis, Sindifargo and Sindusfarma.

Source: Panorama Farmacêutico